CEACAM5 and non-small cell lung carcinoma: Carcinoembryonic antigen (CEA) was also considered as promising target for CAR-T cell therapy in NSCLC, given its overexpression in approximately 70% of NSCLC cases and minimal presence in normal adult tissues [78].